Description: ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, lices, and mange in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle. ECO Animal Health Group plc was founded in 1972 and is based in London, the United Kingdom.
Home Page: www.ecoanimalhealthgroupplc.com
The Grange
London,
N14 6BN
United Kingdom
Phone:
44 208 447 8899
Officers
| Name | Title |
|---|---|
| Mr. David Charles Hallas | CEO & Director |
| Mr. Christopher Wilks ACA, BSc, F.C.A. | CFO, Finance Director, Secretary & Director |
| Mr. Andrew Buglass | Chief Commercial Officer |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 47.3934 |
|---|---|
| Trailing PE: | 81 |
| Price-to-Book MRQ: | 0.554 |
| Price-to-Sales TTM: | 0.6454 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 227 |